Laxmi Dental Q4 PAT Surges 134.88% YoY to INR 101 Million; FY26 Revenue Up 16.2%

4 min read     Updated on 23 May 2026, 01:28 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Laxmi Dental Limited reported a 134.88% YoY surge in Q4FY26 consolidated net profit to INR 100.94 million, with revenue from operations rising 19.54% to INR 722 million. For FY26, consolidated revenue from operations grew 16.2% to INR 2,778.60 million, with EBITDA at INR 434 million and basic EPS of ₹5.53. Standalone FY26 net profit stood at INR 193.37 million, with total income from operations at INR 2,085.56 million.

powered bylight_fuzz_icon
40630462

*this image is generated using AI for illustrative purposes only.

Laxmi Dental Limited has announced its audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026. The company reported quarterly revenue from operations of INR 722 million in Q4FY26, marking a 19.54% year-on-year increase over INR 604 million in Q4FY25. The Board of Directors approved the financial results at its meeting held on May 21, 2026, and the company subsequently submitted copies of newspaper advertisements published in the Financial Express (English) and Mumbai Lakshdeep (Marathi) on May 23, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Consolidated Financial Performance

For the financial year ended March 31, 2026, the company reported a consolidated net profit of INR 289.20 million. Total income for the year stood at INR 2,864.04 million, while revenue from operations increased to INR 2,778.60 million, a 16.2% rise from the previous year. EBITDA for the year was INR 434 million, with a margin of 15.6%. The following table summarises the key consolidated financial metrics for the quarter and full year:

Metric Q4FY26 Q4FY25 YoY Change FY26 FY25 YoY Change
Revenue from Operations (INR Mn) 722.00 604.00 +19.54% 2,778.60 2,391.10 +16.2%
Total Income from Operations (INR Mn) 739.54 606.68 2,778.58 2,391.07
EBITDA (INR Mn) 134.00 96.00 +39.58% 434.00 418.70 +3.6%
EBITDA Margin 18.61% 15.84% +277 bps 15.6%
Profit Before Tax (INR Mn) 111.35 60.10 +85.3% 289.26 318.29 -9.1%
Net Profit After Tax (INR Mn) 100.94 42.75 +134.88% 289.17 325.43 -11.1%
Total Comprehensive Income (INR Mn) 113.67 37.14 303.50 313.00
Basic EPS (₹) 1.83 0.79 5.53 6.20
Diluted EPS (₹) 1.83 0.78 5.50 6.19

Equity share capital stood at INR 109.92 million (face value ₹2 each), while consolidated reserves (excluding revaluation reserve) as shown in the audited balance sheet stood at INR 2,323.28 million for FY26, compared to INR 1,975.45 million in FY25.

Standalone Financial Performance

On a standalone basis, Laxmi Dental reported total income from operations of INR 557.36 million in Q4FY26, compared to INR 426.85 million in Q4FY25. For the full year FY26, standalone total income from operations stood at INR 2,085.56 million, against INR 1,712.44 million in FY25. The table below presents the key standalone financial metrics:

Metric Q4FY26 Q4FY25 FY26 FY25
Total Income from Operations (INR Mn) 557.36 426.85 2,085.56 1,712.44
Net Profit Before Tax (INR Mn) 65.81 64.03 209.70 243.54
Net Profit After Tax (INR Mn) 67.98 41.75 193.37 257.75
Total Comprehensive Income (INR Mn) 73.11 37.39 194.24 252.27
Basic EPS (₹) 1.24 0.77 3.52 4.92
Diluted EPS (₹) 1.23 0.76 3.51 4.91

Standalone reserves (excluding revaluation reserve) stood at INR 2,360.58 million for FY26, compared to INR 2,117.45 million in FY25.

Operational Highlights and Segment Performance

The company achieved a gross profit margin of 70.5% in Q4FY26, with core dental business margins excluding scanner sales remaining steady at approximately 76.0%. Management noted that scanner sales, while lower margin, are strategic and act as enablers for future growth in the Dental Lab and Aligner businesses. The Dental Laboratory business reported its highest-ever quarterly performance with 27% year-on-year growth, driven by a recovery in domestic business and record international revenue. The Aligner Solutions business reported revenue of INR 180 million during the quarter, with the Bizdent clear aligner business witnessing an 11% year-on-year recovery. These segment-level gains underscore the company's diversified revenue base and its continued focus on expanding both domestic and international dental care markets.

Exceptional Items and One-Offs

Financial performance for the year was impacted by several one-off items. The company recorded a one-time expense of INR 57.8 million due to changes in the labour code. Additionally, ESOP expenses for FY26 stood at INR 52.6 million compared to INR 21.9 million in the previous year. The company also recorded a tax benefit of INR 13 million in Q4FY26 related to the gratuity expense recognised in Q3FY26. In the prior year, an exceptional item of INR 70.3 million was recorded pertaining to a gain on property sale.

Historical Stock Returns for Laxmi Dental

1 Day5 Days1 Month6 Months1 Year5 Years
+20.00%+23.14%+25.54%-15.88%-37.04%-54.72%

How will Laxmi Dental's strategic scanner sales investments translate into measurable revenue growth for its Dental Lab and Aligner businesses over the next 2-3 years?

Given the significant jump in ESOP expenses from INR 21.9 million to INR 52.6 million in FY26, how might continued employee stock option dilution impact EPS trajectory in FY27 and beyond?

With the Bizdent clear aligner segment showing only 11% recovery, what competitive pressures from domestic and international aligner brands could limit Laxmi Dental's market share expansion?

Laxmi Dental Limited Announces Non-Deal Roadshow with Elara Capital on April 22, 2026

1 min read     Updated on 17 Apr 2026, 04:33 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Laxmi Dental Limited has scheduled a Non-Deal Roadshow with Elara Capital for April 22, 2026 in Chennai, featuring physical investor meetings starting from 10:00 AM. The company filed the announcement under SEBI Regulation 30, confirming that discussions will be based on publicly available information with no unpublished price sensitive information to be shared.

powered bylight_fuzz_icon
37969423

*this image is generated using AI for illustrative purposes only.

Laxmi Dental Limited has announced its participation in a Non-Deal Roadshow (NDR) with Elara Capital, scheduled for April 22, 2026. The company informed both BSE and NSE about the investor meeting through a regulatory filing dated April 17, 2026.

Meeting Details

The roadshow will take place in Chennai through physical meetings, providing investors with opportunities for direct interaction with company officials. The event details are structured as follows:

Parameter: Details
Date & Time: April 22, 2026 10:00 AM onwards
Organizer: Elara Capital
Meeting Format: 1x1 / Group Meeting
Location: Chennai
Mode: Physical

Regulatory Compliance

The announcement was made pursuant to Regulation 30 read with Para A Part A Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Company Secretary and Compliance Officer Suman Saha signed the regulatory filing, ensuring proper compliance with disclosure requirements.

Discussion Framework

Laxmi Dental Limited has clearly stated that all discussions during the roadshow will be based on publicly available information. The company has emphasized that no unpublished price sensitive information (UPSI) is intended to be discussed during the investor interactions, maintaining transparency and regulatory compliance.

Additional Information

The company has noted that changes to the schedule may occur due to exigencies on the part of participants or the company. Complete details of the roadshow will be made available on the company's website at www.laxmidentallimited.com for stakeholder reference and transparency.

Historical Stock Returns for Laxmi Dental

1 Day5 Days1 Month6 Months1 Year5 Years
+20.00%+23.14%+25.54%-15.88%-37.04%-54.72%

What strategic initiatives or growth plans might Laxmi Dental present to attract institutional investors during this roadshow?

How could this NDR with Elara Capital potentially impact Laxmi Dental's stock liquidity and institutional investor base?

Will this roadshow signal preparations for future fundraising activities or expansion plans in the dental industry?

More News on Laxmi Dental

1 Year Returns:-37.04%